ACRES Launches First Phase of Shared Clinical Research Platform

Article

Applied Clinical Trials

The Alliance for Clinical Research Excellence and Safety (ACRES) announced the launch of ACRES BlueCloud™

The Alliance for Clinical Research Excellence and Safety (ACRES) announced the launch of ACRES BlueCloud™, the first phase implementation of a shared multi-user interface to allow sponsors, CROs, regulatory agencies, funding agencies and IRBs to access verifiable professional experience and training credentials, for sharing and mutual recognition credentials by multiple stakeholders.

The technology also provides a global integration platform through which stakeholders can access and deploy already established technology solutions and collaborative data warehouses to support a global system for high-performance Accountable Research™. ACRES’ strategic ally HealthCarePoint, a Texas-based healthcare and clinical research networking-technology corporation, provides the ACRES BlueCloudcapabilities. HealthCarePoint is among several technology companies and standards organizations comprising ACRES’ global Technology Consortium. Rollout of the ACRES Blue Cloud™ platform will begin immediately by providing the technology free of charge to clinical research sites worldwide, thereby extending and leveraging the existing global network of nearly three-quarter million current BlueCloud™ users from some 60,000 healthcare and research-related organizations worldwide.  The network’s single sign-on interface will allow sites to connect with sponsors, CROs, ethics committees (IRBs) and other stakeholders through a unified platform, sharing critical professional and operational information, such as GCP training certifications and other professional credentials. As other provider technologies integrate with the shared platform through application programming interfaces, commonly known as APIs, additional functionality will be added. 

Read the full release here.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.